ASTRAZEN

Astrazeneca Pharma India Ltd.

NSE: ASTRAZEN

BSE: 506820

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

8,126.00-218.0 (-2.61%)

8 Jul, 12:00 AM

Overview

Analysis Statements Technicals Forecast Peers Resources News

Stock Scores

Quality Score

68.1 / 100

Value Score

6.7 / 100

Price Momentum Score

62.1 / 100

QVM Score

37.8 / 100

Key Metrics

Market Cap

20315.00

P/E (TTM)

108.33

P/B

23.28

P/S (TTM)

8.93

EV/EBITDA

76.21

CAPE (5Y)

162.35

ROE (TTM)

22.82

ROCE (TTM)

26.09

ROA (TTM)

10.69

Avg 3Y ROE

21.09

Earnings 3Y CAGR

23.61

Sales 3Y CAGR

31.40

Sales 5Y CAGR

22.84

Debt/Equity

0.13

Consensus TP

Strong Buy %

Promoter Holding

75.00

Pledged %

0.00

Stock Analysis

Fundamental analysis overview of Astrazeneca Pharma India Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views

Red Flags

Positive

High and improving ROE

The company reported strong ROE of 22.82% for 12-month ended 31 Mar 2026 and ROE improved by 719 bps from 1 year ago

What is ROE (FY)?

Strong revenue growth and above median growth of industry

The company delivered strong revenue growth of 32.59% for 12-month ended 31 Mar 2026 and the growth was 21.35 percentage points higher than median growth of industry

What is Sales growth (1Y)?

Median: 11.24

Value 32.59

-82.35114662

Strong EPS growth and above median growth of industry

The company delivered strong EPS growth of 62.02% for 12-month ended 31 Mar 2026 and the growth was 53.9 percentage points higher than median growth of industry

What is EPS growth (1Y)?

Low Debt to Equity, not much change from last year

The company has low Debt to Equity of 0.13 as on 31 Mar 2026 and Debt to Equity increased marginally by 0.08 in the last 1 year

What is Debt to Equity?

Consistently pays dividend

The company has not missed dividend payments once in the last 7 financial years

What is Dividend streak?

Company is net cash

The company is net cash i.e., cash and cash equivalents exceed total debt indicating a healthy balance sheet

What is Net Debt ?

Negative

Expensive and at a premium to industry median P/E

PE TTM of 108.34 indicates that the stock is expensive on a standalone basis and is at a 256.73% premium to industry median P/E

What is P/E Ratio?

Median: 30.37

Value 108.34

-215.443255.34

Moderate operating margin but declining trend

The company reported moderate operating margin of 10.26% for 12-month ended 31 Mar 2026 but operating margin declined by -221 bps from 1 year ago

What is Operating profit margin?

Company's earnings are of low quality

Earnings quality score of 27.2 indicates that the company's earnings are of low quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion

What is Earnings quality score?

27.2 / 100

Low dividend yield

The company has a low dividend yield of 0.39%

What is Dividend yield?

Neutral

Not enough talking points with neutral stance

Financial Snapshot

See detailed analysis

Multi-year trends for Astrazeneca Pharma India Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY

Profit After Tax FY

ROE FY

EBITDA FY

Astrazeneca Pharma India Ltd. Shareholding Pattern

Quarterly breakdown of Astrazeneca Pharma India Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Promoter	75.00	75.00	75.00	75.00	75.00	75.00	75.00	75.00	75.00	75.00	75.00	75.00	75.00	75.00	75.00	75.00	75.00	75.00	75.00	75.00	75.00	75.00	75.00	75.00	75.00
Indian Promoter	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	75.00	-	-	-	-	-	-	-	-
Foreign Promoter	75.00	75.00	75.00	75.00	75.00	75.00	75.00	75.00	75.00	75.00	75.00	75.00	75.00	75.00	75.00	75.00	-	75.00	75.00	75.00	75.00	75.00	75.00	75.00	75.00
Institutions	4.88	4.58	4.31	3.82	3.36	3.44	3.45	3.52	3.57	3.78	3.81	4.03	4.11	4.59	5.11	5.42	6.50	7.79	8.00	8.14	7.53	7.58	7.99	8.26	8.56
Mutual Funds / UTI	3.45	3.21	2.22	1.37	0.83	0.94	0.93	0.97	0.99	1.07	1.09	1.22	1.22	1.76	2.42	2.75	3.75	4.97	5.05	5.04	4.45	4.33	5.00	5.43	5.66
FI/Bank/Insurance	0.11	0.09	0.02	0.02	0.00	0.00	0.03	0.03	0.03	0.03	0.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.13	0.16	0.18	0.19	0.05	0.06
Govt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FII	1.22	1.19	1.98	2.36	2.43	2.42	2.40	2.38	2.38	2.48	2.49	2.61	2.70	2.68	2.69	2.66	2.73	2.79	2.90	2.92	2.89	3.03	2.74	2.71	2.78
Other Institutions	0.10	0.09	0.09	0.07	0.10	0.08	0.09	0.14	0.17	0.20	0.20	0.20	0.19	0.15	0.00	0.01	0.02	0.02	0.03	0.03	0.03	0.03	0.06	0.06	0.06
Non-Institution	20.12	20.42	20.69	21.18	21.64	21.56	21.55	21.48	21.43	21.22	21.18	20.97	20.89	20.41	19.90	19.58	18.49	17.21	17.01	16.87	17.48	17.42	17.01	16.74	16.44
Bodies Corporate	2.66	2.95	1.63	1.52	1.45	1.22	1.23	1.45	1.73	2.03	1.67	1.46	1.49	1.38	1.55	1.58	1.37	1.33	1.35	1.33	1.36	1.32	1.09	1.15	1.13
Others (incl. Retail) No. of shareholders	17.46 17,357	17.47 24,593	19.06 42,904	19.66 53,577	20.19 63,341	20.34 67,641	20.32 66,035	20.03 61,791	19.70 57,394	19.19 53,609	19.51 48,729	19.51 45,267	19.40 41,817	19.03 38,618	18.35 32,070	18.00 28,704	17.12 29,072	15.88 26,833	15.66 27,264	15.54 26,966	16.12 32,053	16.10 33,935	15.92 32,528	15.59 31,146	15.31 28,606

Holdings and Presence

Indices and prominent investors with a stake in this stock.

Index Presence

#	Index	Weight	Rank
1	SHI: Biotech	6.59%	6 / 15
2	Nifty 500 Momentum Quality 50	0.36%	46 / 50

Prominent Investor Holdings

Shivani Tejas Trivedi

Mar 2026

2.40%

₹ 488 Cr

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Astrazeneca Pharma India Ltd. shares as reported to NSE and BSE.

Name	Date	Type	Price	Qty.	Value
Ishares Core Emerging Markets Mauritius Co	19 Sep 2022	sell	₹ 3,152.55	74.10 k	₹ 23.36 cr
Ishares Core Msci Emerging Markets Etf	19 Sep 2022	buy	₹ 3,152.55	74.10 k	₹ 23.36 cr
Ishares India Sc Mauritius Company	19 Sep 2022	sell	₹ 3,152.55	6.54 k	₹ 2.06 cr
Ishares Msci India Small-Cap Etf	19 Sep 2022	buy	₹ 3,152.55	6.54 k	₹ 2.06 cr

Corporate Actions

History of Astrazeneca Pharma India Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.

Dividend₹ 32/share
Record date: 18th Jul 2025Ex-date: 18th Jul 2025
Announced on: 30th May 2025
Dividend₹ 24/share
Record date: 5th Jul 2024Ex-date: 5th Jul 2024
Announced on: 27th May 2024
Dividend₹ 16/share
Record date: 14th Jul 2023Ex-date: 14th Jul 2023
Announced on: 30th May 2023
Dividend₹ 8/share
Record date: 8th Jul 2022Ex-date: 7th Jul 2022
Announced on: 26th May 2022
Dividend₹ 2/share
Record date: 20th Aug 2021Ex-date: 18th Aug 2021
Announced on: 9th Aug 2021

Company Profile

Overview of Astrazeneca Pharma India Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

AstraZeneca Pharma India Limited is an India-based biopharmaceutical company. Its therapeutic areas include cardiovascular, renal and metabolism; chronic and respiratory diseases. The Company operates through Healthcare segment. The Company is engaged in the business of manufacture, distribution and...

Key personnel

Ms. Tanya Sanish

Compliance Officer, Company Secretary

Ms. Shilpa Divekar NirulaD

Non-Executive Independent Chairman of the Board

Mrs. Bhavana AgrawalD

Chief Financial Officer, Whole-time Director

Mr. Praveen Rao AkkinepallyD

Managing Director, Executive Director

Ms. Hooi-Bien ChuahD

Non-Executive Director

Ms. Revathy AshokD

Non-Executive Independent Director

Ms. Monica WidhaniD

Non-Executive Independent Director

Ms. Monica WidhaniD

Non-Executive Independent Director

View all

Incorporated on

11 Jul 1979

Last Annual

31 Mar 2026

Last Interim

31 Mar 2026

No. of Employees

IPO date

30 Jul 1998

Free Float

46,04,471

Website

https://www.astrazeneca.in/

Phone no.

+918067748000

Address

BLOCK N1, 12TH FLOOR,MANYATA EMBASSY BUSINESS PARK RACHENAHALLI, OUTER RING ROAD BANGALORE, , 560045, India

Frequently Asked Questions

What is the current share price of Astrazeneca Pharma India Ltd.?

The current share price of Astrazeneca Pharma India Ltd. is ₹ 8,126.00 as of 8 Jul 2026.

What is the market capitalisation of Astrazeneca Pharma India Ltd.?

The market capitalisation of Astrazeneca Pharma India Ltd. stands at ₹ 20,315.00 Cr.

What is the PE ratio of Astrazeneca Pharma India Ltd.?

The Price-to-Earnings (PE) ratio of Astrazeneca Pharma India Ltd. is 108.33 as of the latest trailing twelve months data.

What is the ROE and ROCE of Astrazeneca Pharma India Ltd.?

Astrazeneca Pharma India Ltd. has a Return on Equity (ROE) of 22.82% and a Return on Capital Employed (ROCE) of 26.09% as per the latest financial reports.

What is the 52-week high and low of Astrazeneca Pharma India Ltd.?

The 52-week high of Astrazeneca Pharma India Ltd. is - and the 52-week low is -.

What is the dividend yield of Astrazeneca Pharma India Ltd.?

The dividend yield of Astrazeneca Pharma India Ltd. is 0.39% based on the current market price.

What is the FII and DII holding in Astrazeneca Pharma India Ltd.?

Foreign Institutional Investors (FII) hold 2.78%, Domestic Institutional Investors (DII) hold 5.72% and retail/public investors hold 15.31% of Astrazeneca Pharma India Ltd. shares.

What sector does Astrazeneca Pharma India Ltd. belong to?

Astrazeneca Pharma India Ltd. operates in the Healthcare sector.

What is the beta of Astrazeneca Pharma India Ltd.?

The beta of Astrazeneca Pharma India Ltd. is 0.51, indicating its price volatility relative to the broader market. Over the past 1 year, Astrazeneca Pharma India Ltd. has delivered an absolute return of -8.78%.

What is the RSI of Astrazeneca Pharma India Ltd.?

The 14-day Relative Strength Index (RSI) of Astrazeneca Pharma India Ltd. is 41.17, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.

Astrazeneca Pharma India Ltd.

Stock Scores

Key Metrics

Share Price

Stock Analysis

Financial Snapshot

Astrazeneca Pharma India Ltd. Shareholding Pattern

Holdings and Presence

Bulk, Block and Insider Trades

Corporate Actions

Company Profile

Frequently Asked Questions

Stock Analysis

Corporate Actions

Company Profile

Holdings and Presence